| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |